Articles by Rachel Grabenhofer, Chief Editor

Global business strategy-GettyImages-2148450586
Can Standardizing Protocols Improve Clinical Supply Execution?
M11 may standardize protocol information, but as experts explain here, successful clinical supply execution depends on much more than what’s in the protocol.  Continue Reading..
problem-solving and partnership-GettyImages-2230067306
Root Causes, Part 5: The Structural Changes Clinical Supply Needs
This fifth and final installment of our Root Causes video series explores the structural changes needed to improve clinical trial execution and clinical supply outcomes.  Continue Reading..
detour road closed-GettyImages-1452886483
Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
This fourth installment of our Root Causes video series examines why even the most well-planned clinical trials often push supply and operations into firefighting mode.  Continue Reading..
businesswoman hiding behind stack folders-GettyImages-915451280
Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
This third installment of our Root Causes video series examines how administrative complexity can consume resources that might otherwise improve clinical trial execution.  Continue Reading..
emotions, realtions, care, understanding-GettyImages-1365340256
Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
This second installment of our Root Causes video series explores how protocol assumptions can create downstream operational and clinical supply challenges.  Continue Reading..
Plant Root System-GettyImages-2259702838
Root Causes, Part 1: When Trial Design Locks In Supply Risk
This first installment of our new Root Causes video series examines how decisions made long before execution can shape clinical supply outcomes.  Continue Reading..
CSUP Two Board Additions 450 x 300
Expanded Expertise, Deeper Insight: Clinical Supply Leader Welcomes Two New Advisors
Clinical Supply Leader expands its Editorial Advisory Board expertise with the addition of Éamonn McArdle (Allergy Therapeutics) and Juan Hernandez (Bensen Solutions).  Continue Reading..
Project manager working and update tasks-GettyImages-2237447392
Could Smarter Use of Clinical Supply Data Help Avoid Certain Protocol Amendments?
Clinical supply data reveals where protocol assumptions break down. Could those lessons help improve protocol design and reduce avoidable amendments?  Continue Reading..
contractors, engineers, supervise-GettyImages-1456699734
Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
Having previously explained why early-stage biotechs should avoid overbuilding, Alicia Collins, of Tune Therapeutics, continues the discussion here in part 2, with thoughts on scaling clinical supply, selecting partners, and preparing for future constraints.  Continue Reading..
Team collaboration, planning for property development-GettyImages-1796900872
The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
Early-stage biotechs often overbuild systems too soon. Alicia Collins, of Tune Therapeutics, explains why flexibility, simple processes, and realistic assumptions matter most.  Continue Reading..

RACHEL GRABENHOFER

RachelRachel Grabenhofer is the Chief Editor and community ambassador for Clinical Supply Leader. Her ambition is to uncover solutions to the unique challenges faced by professionals specializing in clinical supply for pharma R&D.

She achieves such by engaging leading experts and organizations dedicated to this niche space, expressing their insights through interviews, thought leadership pieces, multimedia content – including panel discussions, videos, podcasts – and more.

Rachel’s curiosity and love for science have guided her path to clinical supply. She brings 25 years of editorial experience in trade media focused on ingredient chemistry, skin physiology, pharmacological dynamics, toxicology and regulatory constraints for cosmetics and personal care product development. 

She built a global following as the Managing Scientific Editor of Cosmetics & Toiletries – a role that carried her around the world to give podium presentations, moderate panel discussions, serve as awards juror, chair conferences, visit cosmetic R&D labs and manufacturing facilities, and more.

Most recently, she presented on integrating biotechnology into beauty during the April 2025 In-Cosmetics Global trade show in Amsterdam. She also judged the 2026 Cosmetics Victories competition for Cosmetics360 in Paris.

In her downtime, Rachel enjoys yoga, hiking and tending to her tomatoes. She’s an avid enthusiast of her son’s bowling and swimming, and an unwavering Chicago Bears fan. She is also a passionate advocate for autism awareness.

Connect on LinkedIn